BDBM374757 US10246467, Example I-41::US10919913, # I-41

SMILES [#6]\[#6](-[#6])=[#6]/[#6]-[#7]1-[#6@H]-2-[#6]-[#8]-c3n(nc4cc(ccc34)-[#6](-[#8])=O)-[#6@H]-2-[#6@H](-c2cccc(Cl)c2F)[C@]11[#6](=O)-[#7]-c2cc(Cl)ccc12

InChI Key InChIKey=QFJKZQDZTQLAPD-NCRFVDKVSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 374757   

TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM374757(US10246467, Example I-41 | US10919913, # I-41)
Affinity DataIC50:  40nMAssay Description:This assay is used to determine whether the compounds inhibit the p53-MDM2 interaction and thus restore p53 function.15 μL of compound in 20% DM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117](Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM374757(US10246467, Example I-41 | US10919913, # I-41)
Affinity DataIC50:  40nMAssay Description:This assay is used to determine whether the compounds inhibit the p53-MDM2 interaction and thus restore p53 function.15 μL of compound in 20% DM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent